Saag MS - Search Results

1

Assessment of antiretroviral therapy by plasma viral load testing: standard and ICD HIV-1 p24 antigen and viral RNA (QC-PCR) assays compared.

Kappes JC, Saag MS, Shaw GM, Hahn BH, Chopra P, Chen S, Emini EA, McFarland R, Yang LC, Piatak M Jr, et al. Kappes JC, et al. Among authors: saag ms. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 1;10(2):139-49. doi: 10.1097/00042560-199510020-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552477 Clinical Trial.

2

High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

Saag MS, Crain MJ, Decker WD, Campbell-Hill S, Robinson S, Brown WE, Leuther M, Whitley RJ, Hahn BH, Shaw GM. Saag MS, et al. J Infect Dis. 1991 Jul;164(1):72-80. doi: 10.1093/infdis/164.1.72. J Infect Dis. 1991. PMID: 1676046

3

High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection.

Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, Veldkamp PJ, Kappes JC, Hahn BH, Shaw GM. Clark SJ, et al. Among authors: saag ms. N Engl J Med. 1991 Apr 4;324(14):954-60. doi: 10.1056/NEJM199104043241404. N Engl J Med. 1991. PMID: 1900576 Free article.

4

Individuals infected with HIV possess antibodies against IL-2.

Bost KL, Hahn BH, Saag MS, Shaw GM, Weigent DA, Blalock JE. Bost KL, et al. Among authors: saag ms. Immunology. 1988 Dec;65(4):611-5. Immunology. 1988. PMID: 2464543 Free PMC article.

5

Biologically diverse molecular variants within a single HIV-1 isolate.

Fisher AG, Ensoli B, Looney D, Rose A, Gallo RC, Saag MS, Shaw GM, Hahn BH, Wong-Staal F. Fisher AG, et al. Among authors: saag ms. Nature. 1988 Aug 4;334(6181):444-7. doi: 10.1038/334444a0. Nature. 1988. PMID: 2841608

6

Extensive variation of human immunodeficiency virus type-1 in vivo.

Saag MS, Hahn BH, Gibbons J, Li Y, Parks ES, Parks WP, Shaw GM. Saag MS, et al. Nature. 1988 Aug 4;334(6181):440-4. doi: 10.1038/334440a0. Nature. 1988. PMID: 3405290

7

Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection?

Kilby JM, Saag MS. Kilby JM, et al. Among authors: saag ms. Infect Agents Dis. 1994 Dec;3(6):313-23. Infect Agents Dis. 1994. PMID: 7534192 Review.

8

An approach to antiretroviral treatment of HIV disease. The situation: an overview.

Saag MS. Saag MS. Hosp Pract (1995). 1995 Aug;30 Suppl 1:3-4. Hosp Pract (1995). 1995. PMID: 7635915 No abstract available.

9

A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.

Saag MS, Emini EA, Laskin OL, Douglas J, Lapidus WI, Schleif WA, Whitley RJ, Hildebrand C, Byrnes VW, Kappes JC, et al. Saag MS, et al. N Engl J Med. 1993 Oct 7;329(15):1065-72. doi: 10.1056/NEJM199310073291502. N Engl J Med. 1993. PMID: 7690462 Free article. Clinical Trial.

10

Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.

Cao Y, Ho DD, Todd J, Kokka R, Urdea M, Lifson JD, Piatak M Jr, Chen S, Hahn BH, Saag MS, et al. Cao Y, et al. Among authors: saag ms. AIDS Res Hum Retroviruses. 1995 Mar;11(3):353-61. doi: 10.1089/aid.1995.11.353. AIDS Res Hum Retroviruses. 1995. PMID: 7786581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters